From a former CEO moving to lead the largest hedge fund in the world to endometriosis surgeons claiming the payer is unjustly denying claims, here are five recent stories about Aetna, as reported by Becker's Hospital Review:
Payer
Regence is partnering with kidney care provider Strive Health on a care program for Medicare Advantage members with advanced chronic or end-stage kidney disease.
After receiving an audit from the Pennsylvania Insurance Department, UPMC must pay out $250,000 for claims and notification violations, the Pittsburgh Post-Gazette reported Dec. 30.
Mark Bertolini, former CEO of Aetna, was named co-CEO of Bridgewater Associates, the largest hedge fund in the world, according to a Jan. 3 news release.
Humana is opening a primary care facility in Gresham, Ore., to provide value-based care to its Medicare Advantage members, the payer announced Jan. 3.
Nearly 3 in 5 Americans believe their insurance should better cover mental healthcare, including therapy visits, according to a ValuePenguin survey released Jan. 3.
UnitedHealthcare is extending its relationship with human resources and benefits administrator Insperity through 2026.
Biogen slashed the price of its controversial Alzheimer's drug Aduhelm after a problematic rollout, but the move has still done little to encourage Medicare to cover the controversial drug.
Nearly 400,000 patients affected by a contract dispute between Anthem and Atlanta-based Northside Hospital System will maintain in-network rates for another month after a judge issued an injunction.
More than 27 million Americans are enrolled in Medicare Advantage plans, and insurers are signaling it may be a fruitful market worth more of their resources, according to Forbes.
